Works by Hongwei Yao


Results: 137
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT-PD1-LARC trial).

    Published in:
    2022
    By:
    • Yang, Zhengyang;
    • Zhang, Xiao;
    • Zhang, Jie;
    • Gao, Jiale;
    • Bai, Zhigang;
    • Deng, Wei;
    • Chen, Guangyong;
    • An, Yongbo;
    • Liu, Yishan;
    • Wei, Qi;
    • Han, Jiagang;
    • Li, Ang;
    • Liu, Gang;
    • Sun, Yi;
    • Kong, Dalu;
    • Yao, Hongwei;
    • Zhang, Zhongtao
    Publication type:
    journal article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56955-y
    By:
    • Liao, Chengheng;
    • Hu, Lianxin;
    • Jia, Liwei;
    • Zhou, Jin;
    • Wang, Tao;
    • Kim, Kangsan;
    • Zhong, Hua;
    • Yao, Hongwei;
    • Dong, Lei;
    • Guo, Lei;
    • Liang, Qian;
    • Zhang, Cheng;
    • Zhao, Fangzhou;
    • Fang, Jun;
    • Liu, Hongyi;
    • Li, Shina;
    • Xu, Lin;
    • Simon, Jeremy M.;
    • Malladi, Srinivas;
    • Kapur, Payal
    Publication type:
    Article
    36
    37
    38
    39
    40

    MoNbTaV Medium-Entropy Alloy.

    Published in:
    Entropy, 2016, v. 18, n. 5, p. 189, doi. 10.3390/e18050189
    By:
    • Hongwei Yao;
    • Jun-Wei Qiao;
    • Gao, Michael C.;
    • Hawk, Jeffrey A.;
    • Sheng-Guo Ma;
    • Hefeng Zhou
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50